ID-ONE Cosmo dual interface card for multiple secure applications launched by Oberthur Technologies

Oberthur Technologies, a global leader in the delivery of high security solutions and the #1 provider of credentials to the U.S. Federal government, announces the availability of its dual interface ID-ONE™ Cosmo card to the Corporate Market at the ASIS International 55th Annual Seminar, September 21-24 at the Anaheim Convention Center in Anaheim, CA. The ID-ONE Cosmo card is a dual interface card that offers an open platform for multiple secure applications, providing companies with a single card solution with two communication interfaces -- contactless for physical access and contact for logical access, based upon open, interoperable standards.

The ID-One Cosmo card is fully compliant with Federal Homeland Security Presidential Directive 12 (HSPD-12) mandates for identification standards, including FIPS 201 the baseline requirements for a Federal Personal Identification Verification (PIV) system.

The ID-ONE Cosmo card offers the corporate market a rigorously tested, federally compliant ID card with a profile that supports both physical and logical access with the addition of cashless payment, or other applications of your choosing, on one card.

"ID-ONE Cosmo provides the perfect solution for the needs of corporations -- striking the perfect balance between convenience and interoperability without sacrificing security," says Xavier Fricout, Deputy Managing Director for the Identity Division.

"Our success in offering both a physical and logical security access solution for the Federal Government made this move into the corporate world seamless," says Patrick Hearn, Oberthur's VP of Government and Identification Markets for North America. "Companies are reassured to know that the technology has been proven, tested and is available for their use in a single card solution."

SOURCE: Oberthur Technologies of America Corp.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.